Giovanna Rege Cambrin

Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia

Gianantonio Rosti, Francesca Palandri, Fausto Castagnetti et al. · Blood · 2009 · 211 citations · Full text

Medicine, Oncology, Pharmacology +7

New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia

Giuseppe Saglio, A Guerrasio, C Rosso et al. · Blood · 1990 · 151 citations · Full text

Life Sciences, Genetics, Hematology +15

Molecular response to imatinib in late chronic-phase chronic myeloid leukemia

Gianantonio Rosti, Giovanni Martinelli, Simona Bassi et al. · Blood · 2003 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +8

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party

Fausto Castagnetti, Francesca Palandri, Marilina Amabile et al. · Blood · 2009 · 70 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

G. Rosti, Ilaria Iacobucci, Simona Bassi et al. · Haematologica · 2007 · 63 citations · Full text

Education, Geriatric Medicine, Hematology +10